Atypical antipsychotics: enhancing healthy outcomes.
Casey
Daniel E
DE
Mental Illness Research, Education and Clinical Center, MIRECC VISN 20, Portland VA Medical Center and the Department of Psychiatry, Oregon Health Sciences University, Portland, OR 97201, USA. Daniel.casey@med.va.gov
D014150:Antipsychotic Agents / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000517:prevention & control*; D003920:Diabetes Mellitus / Q000139:chemically induced / Q000453:epidemiology; D006801:Humans; D009765:Obesity / Q000139:chemically induced / Q000453:epidemiology; D012307:Risk Factors; D012559:Schizophrenia / Q000150:complications* / Q000188:drug therapy* / Q000401:mortality; D012907:Smoking / Q000453:epidemiology
D014150:Antipsychotic Agents